Bioelectronics Corp (BIEL)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.397M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -50.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 98.65% |
Profile
| Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and consumers. |
| URL | https://www.bielcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | Maryland |
| Sector | |
| Industry | |
| Equity Style | N/A |
| Next Earnings Release | Jun. 14, 2024 (est.) |
| Last Earnings Release | Jun. 15, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and consumers. |
| URL | https://www.bielcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | Maryland |
| Sector | |
| Industry | |
| Equity Style | N/A |
| Next Earnings Release | Jun. 14, 2024 (est.) |
| Last Earnings Release | Jun. 15, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |